New COO at Biogen Idec
This article was originally published in Scrip
Biogen Idec has named Robert Hamm chief operating officer. He has been executive vice-president of pharmaceutical operations & technology since 2007. Mr Hamm succeeds Hans Peter Hasler, who is leaving the company.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.